These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34361978)

  • 1. A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.
    Van Daele R; Bekkers B; Lindfors M; Broman LM; Schauwvlieghe A; Rijnders B; Hunfeld NGM; Juffermans NP; Taccone FS; Coimbra Sousa CA; Jacquet LM; Laterre PF; Nulens E; Grootaert V; Lyster H; Reed A; Patel B; Meersseman P; Debaveye Y; Wauters J; Vandenbriele C; Spriet I
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study.
    Ye Q; Yu X; Chen W; Li M; Gu S; Huang L; Zhan Q; Wang C
    Front Pharmacol; 2022; 13():972585. PubMed ID: 36059951
    [No Abstract]   [Full Text] [Related]  

  • 3. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
    Ronda M; Llop-Talaveron JM; Fuset M; Leiva E; Shaw E; Gumucio-Sanguino VD; Diez Y; Colom H; Rigo-Bonnin R; Puig-Asensio M; Carratalà J; Padullés A
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
    Peterson EL; Chittick PJ; Richardson CL
    Transpl Infect Dis; 2021 Jun; 23(3):e13545. PubMed ID: 33316840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
    Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
    J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
    Mathieu A; Thiboutot Z; Ferreira V; Benoit P; Grandjean Lapierre S; HÉtu PO; Halwagi A
    ASAIO J; 2022 Mar; 68(3):e56-e58. PubMed ID: 33788798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
    Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
    J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
    Vu T; Feih J; Juul J
    J Pharm Pract; 2023 Aug; 36(4):998-1001. PubMed ID: 35612553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
    Van Daele R; Brüggemann RJ; Dreesen E; Depuydt P; Rijnders B; Cotton F; Fage D; Gijsen M; Van Zwam K; Debaveye Y; Wauters J; Spriet I
    J Antimicrob Chemother; 2021 Apr; 76(5):1234-1241. PubMed ID: 33517360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
    Kriegl L; Hatzl S; Zurl C; Reisinger AC; Schilcher G; Eller P; Gringschl Y; Muhr T; Meinitzer A; Prattes J; Hoenigl M; Krause R
    J Antimicrob Chemother; 2022 Aug; 77(9):2500-2505. PubMed ID: 35726095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review.
    Mertens B; Elkayal O; Dreesen E; Wauters J; Meersseman P; Debaveye Y; Degezelle K; Vermeersch P; Gijsen M; Spriet I
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid.
    Van Daele R; Wauters J; De Cock P; Buyle F; Leys J; Van Brantegem P; Gijsen M; Annaert P; Debaveye Y; Lagrou K; Peetermans WE; Brüggemann RJ; Spriet I
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable Sequestration of Antifungals in an Extracorporeal Membrane Oxygenation Circuit.
    Lyster H; Pitt T; Maunz O; Diamond S; Roberts JA; Brown D; Mills J; Armstrong-James D; Gerovasili V; Carby M; Dunning J; Simon A; Reed A
    ASAIO J; 2023 Mar; 69(3):309-314. PubMed ID: 36731055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequestration of Voriconazole and Vancomycin Into Contemporary Extracorporeal Membrane Oxygenation Circuits: An
    Raffaeli G; Cavallaro G; Allegaert K; Koch BCP; Mosca F; Tibboel D; Wildschut ED
    Front Pediatr; 2020; 8():468. PubMed ID: 32974242
    [No Abstract]   [Full Text] [Related]  

  • 16. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study.
    Mané C; Delmas C; Porterie J; Jourdan G; Verwaerde P; Marcheix B; Concordet D; Georges B; Ruiz S; Gandia P
    J Transl Med; 2020 May; 18(1):213. PubMed ID: 32460856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
    Fillâtre P; Lemaitre F; Nesseler N; Schmidt M; Besset S; Launey Y; Maamar A; Daufresne P; Flecher E; Le Tulzo Y; Tadie JM; Tattevin P
    J Antimicrob Chemother; 2021 Apr; 76(5):1242-1249. PubMed ID: 33569597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.
    Marella P; Roberts J; Hay K; Shekar K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
    Bienvenu AL; Pradat P; Plesa A; Leclerc V; Piriou V; Fellahi JL; Argaud L; Rimmelé T; Menotti J; Aubrun F; Richard JC; Gagnieu MC; Parant F; Chidiac C; Leboucher G; Tod M; Goutelle S
    PLoS One; 2021; 16(11):e0260656. PubMed ID: 34818379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.